WHO ICTRP trial

TriMaximize: A multicentre, prospective, non-interventional trial monitoring…

DRKS00024724 · German Clinical Trials Register · Recruiting

Key facts

Trial ID DRKS00024724
Public title TriMaximize: A multicentre, prospective, non-interventional trial monitoring therapy pathways of Asthma patients treated with an extra-fine ICS/LABA/LAMA single-inhaler triple therapy in a real-world setting and characterizing the effects on health-related outcomes
Scientific title TriMaximize: A multicentre, prospective, non-interventional trial monitoring therapy pathways of Asthma patients treated with an extra-fine ICS/LABA/LAMA single-inhaler triple therapy in a real-world setting and characterizing the effects on health-related outcomes - TriMaximize
Primary sponsor Chiesi GmbH
Registry German Clinical Trials Register
Recruitment status Recruiting
Study type observational
Countries Austria;Germany;Denmark;Spain;France;United Kingdom;Italy;Poland
Conditions J45;Asthma
Interventions Group 1: Trimbow® 87 microgram/5 microgram / 9 microgram pressurized inhalation, solution or Trimbow® 172 microgram /5 microgram / 9 microgram pressurized inhalation, solution. The dates for the visits to the practice are based on the…
Registration date Mar 25, 2021
Target size 3950
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations